Closing Thoughts on Iron Deficiency Anemia

Panelists discuss how the successful management of iron deficiency anemia requires a comprehensive approach combining early detection, appropriate choice of iron formulation, careful monitoring of treatment response, and addressing barriers to care while emphasizing the importance of patient education and health care system support in achieving optimal outcomes.

EP: 1.Background and Causes of Iron Deficiency Anemia

EP: 2.Pathophysiology of Iron Deficiency Anemia

EP: 3.Symptoms and Epidemiology of Iron Deficiency Anemia

EP: 4.Diagnosis and Common Comorbidities Seen With Iron Deficiency Anemia

EP: 5.Monitoring Patients With Iron Deficiency Anemia After Diagnosis

EP: 6.Oral vs IV Iron in Clinical Practice

EP: 7.FDA-Approved IV Iron Formulations

EP: 8.Factoring in Safety Considerations With IV Iron Products

EP: 9.Adverse Effects Associated With Hypophosphatemia

EP: 10.Clinical Impact of Hypophosphatemia

EP: 11.Clinical and Economic Consequences of Nonadherence to IV Iron

EP: 12.Adherence and Time Spent Receiving IV Iron Infusions

EP: 13.Step Edits Associated with IV Iron Therapies

EP: 14.The Future of IV Iron Administration

Now Viewing

EP: 15.Closing Thoughts on Iron Deficiency Anemia

Related Videos

Related Content

Advertisement

February 26th 2025

RA-Specific Physical Activity Resources Provide Guidance but Need Improvement

Brooke McCormick

An extensive library of physical activity resources will better support the different needs, capabilities, and considerations of patients with rheumatoid arthritis (RA), according to the researchers.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Published: February 25th 2025 | Updated: February 25th 2025

Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane

Julia Bonavitacola

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 24th 2025

Similar Chronic Condition Rates in MA, FFS Beneficiaries Raise Concerns About Overpayments to MA Plans

Brooke McCormick

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices rather than differences in disease burden between MA and fee-for-service (FFS) Medicare beneficiaries.

February 24th 2025

Telemedicine May Reduce Low-Value Testing and Related Costs in Medicare Beneficiaries

Brooke McCormick

Higher telemedicine adoption among Medicare beneficiaries was associated with a slight increase in total visits but a reduction in certain low-value tests and related spending.

Related Content

Advertisement

February 26th 2025

RA-Specific Physical Activity Resources Provide Guidance but Need Improvement

Brooke McCormick

An extensive library of physical activity resources will better support the different needs, capabilities, and considerations of patients with rheumatoid arthritis (RA), according to the researchers.

December 23rd 2024

Five Years Later: Ongoing COVID-19 Challenges, Next Steps

Brooke McCormick

On this episode of Managed Care Cast, we speak with Jenny Han, MD, of Emory School of Medicine and Grady Hospital, about COVID-19, long COVID, and strategies for prevention and care.

Published: February 25th 2025 | Updated: February 25th 2025

Dry Eye Symptom Frequency, Severity Reduced When Using Perfluorohexyloctane

Julia Bonavitacola

Perfluorohexyloctane ophthalmic solution had high treatment satisfaction in those who took it for dry eye.

December 17th 2024

Diving Into Patient Preferences for Blood Cancer Treatments With Dr Sikander Ailawadhi

Three abstracts presented at the 2024 American Society of Hematology annual meeting focused on patient preferences and treatment choices in blood cancers.

February 24th 2025

Similar Chronic Condition Rates in MA, FFS Beneficiaries Raise Concerns About Overpayments to MA Plans

Brooke McCormick

These findings support the claim that Medicare Advantage (MA) payments may be driven more by diagnosis and coding practices rather than differences in disease burden between MA and fee-for-service (FFS) Medicare beneficiaries.

February 24th 2025

Telemedicine May Reduce Low-Value Testing and Related Costs in Medicare Beneficiaries

Brooke McCormick

Higher telemedicine adoption among Medicare beneficiaries was associated with a slight increase in total visits but a reduction in certain low-value tests and related spending.